Medical Devices & Surgical Technology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices & Surgical Technology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Stem Cell Research
Baxter Representative Joins Progenitor Cell Therapy Board of Managers
July 22nd, 2007
Progenitor Cell Therapy, LLC (PCT) announced the addition of Mr. Paul Estrem to its Board of Managers. Mr. Estrem will replace Mr. Victor W. Schmitt as Baxter's representative on the PCT Board. PCT benefited from Mr. Schmitt's dedicated service on its Board from 2003 to 2007. "Victor was a staunch advocate of our corporate vision and mentor to our Executives. His guidance was appreciated and valued. We wish him continued success," says PCT's CEO Dr. Andrew L. Pecora. Paul Estrem, age 42, brings a wealth of expertise and experience to PCT's Board of Managers. Paul, with Baxter since 1990, is the Chief Financial Officer for Baxter's BioScience Division and the President...
Source: Medical Devices & Surgical Technology Week (2007-07-22)
|
